Two tools for the same shadow — working at different depths
Most people comparing tear trough filler with fat repositioning are trying to fix the same picture: a groove under the eye that reads as tiredness. But the two approaches act on different layers of the problem. Filler adds volume on top of the existing structure to soften how the groove looks. Repositioning changes the structure itself — releasing the ligament that tethers the groove to the bone and moving the orbital fat that creates the bulge above it. One is a cover; the other is a correction. Neither is universally better, and a clinic that only ever recommends the one procedure it sells is answering its own question rather than yours.
What filler genuinely does well
Filler has real advantages: no operation, minimal downtime, a visible change the same week, and — for hyaluronic-acid products — reversibility with a dissolving enzyme if the result disappoints. For a selected patient with a mild groove, no significant fat bulge, reasonable skin, and no previous surgery in the area, a carefully placed conservative filler treatment can be a legitimate choice. ST says this plainly because pretending filler never works would be as dishonest as pretending it always does. The question is not whether filler can look good — it can — but whether your particular under-eye is the kind it works for, and for how long.
Where filler reaches its limits
Filler adds; it cannot release or move anything. If your groove is held down by a tethered tear-trough ligament, material injected above it softens the line while the structure that creates it stays put — a cover over the symptom, not a correction of the cause. If there is a true fat bulge, filler placed in the groove below can make the whole under-eye look heavier and puffier rather than fresher. And the under-eye is one of the least forgiving areas to inject: the skin is thin, it moves constantly, and material placed too superficially can show as swelling, bluish discoloration, or visible lumps. These are not rare theoretical risks — they are the most common reasons filler patients later seek correction.
The repeat-cycle problem nobody prices in
Hyaluronic-acid filler is temporary by design, so maintaining the look means repeating the treatment. Each session seems small next to surgery, but the comparison most patients actually face is years of repetition against a single structural correction — in money, in appointments, and in cumulative risk, because every re-injection into thin, mobile tissue is a fresh chance for unevenness, and layered old material makes the under-eye progressively harder to assess and correct later. None of this makes filler wrong. It means the honest comparison is not “an injection versus an operation” but “a maintenance cycle versus a one-time correction,” and you should decide with that frame in view.
What repositioning does that filler cannot
Fat repositioning treats the two structural causes at once: the tethered groove is surgically released, and the orbital fat that formed the bulge is preserved, moved over the rim into the groove, and fixed in place. Because the correction uses your own living tissue and changes the anatomy rather than padding it, the result does not dissolve on a schedule — though no surgeon should call any result permanent, since tissue continues to age. The trade-offs are real and should be stated just as clearly: it is an operation, with one to two weeks of visible bruising and swelling, a contour that refines over one to two months, and it demands more of the surgeon than an injection does.
A practical way to decide
Strip the marketing away and the decision usually reduces to three questions. First, what is actually causing your shadow — a mild volume dip, or a bulge-and-tether structure? The first can suit filler; the second will outlast every syringe. Second, what is your horizon — a look for this year, or a correction you do not want to maintain? Third, what is your history — previous filler, fat grafting, or surgery in the area shifts the calculation toward assessment first, because adding material to an already-treated under-eye is where most bad outcomes start. A diagnosis-first consultation should tell you which side of these lines you fall on, including when the answer is that filler elsewhere — or nothing at all — serves you better than surgery.
If you already have filler and are considering surgery
Many repositioning patients arrive with filler already in place, sometimes years of it. That does not rule out surgery, but it changes the order of operations: the surgeon first needs to know what was injected, when, and where it sits, because residual material distorts both the diagnosis and the surgical plane. Some cases call for dissolving hyaluronic acid before reassessment; others can be planned around it. What you should not do is add more material to “tide you over” while deciding — every additional layer makes the eventual correction harder to judge. Bring your injection history to the consultation and let the plan start from what is actually under the skin.